Undisclosed Targets

We are applying our proprietary fluorine-based medicinal chemistry platform to generate novel, patentable compounds against undisclosed immuno-oncology targets. These programs are currently in the discovery phase.

EMAIL ALERTS

Email Address: *
First Name:
Mailing Lists




 
Enter the code shown above.

Powered By Q4 Inc. 5.4.0.3